Journal article
Association of Fludeoxyglucose F 18-Labeled Positron Emission Tomography and Computed Tomography With the Detection of Oropharyngeal Cancer Recurrence.
Abstract
Importance: No guidelines at present describe when fludeoxyglucose F 18-labeled positron emission tomography and computed tomography (FDG PET-CT) should be used in the initial posttreatment period for evaluation of oropharyngeal squamous cell carcinoma treatment outcome and recurrence.
Objective: To compare accuracies of the initial posttreatment PET-CT between primary treatment groups and to define indicators of false-positive findings.
Authors
Sivarajah S; Isaac A; Cooper T; Zhang H; Puttagunta L; Abele J; Biron V; Harris J; Seikaly H; O' Connell DA
Journal
JAMA Otolaryngology - Head & Neck Surgery, Vol. 144, No. 11, pp. 1037–1043
Publisher
American Medical Association (AMA)
Publication Date
November 1, 2018
DOI
10.1001/jamaoto.2018.2143
ISSN
2168-6181